SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-18-000099
Filing Date
2018-10-02
Accepted
2018-10-02 17:06:53
Documents
5
Period of Report
2018-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca8k10118.htm 8-K 27764
2 EXHIBIT 99.1 exhibit99110118.htm EX-99.1 5907
3 exhibit99110118001.jpg GRAPHIC 179699
4 exhibit99110118002.jpg GRAPHIC 205109
5 exhibit99110118003.jpg GRAPHIC 28384
  Complete submission text file 0001457612-18-000099.txt   604411
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 181102357
SIC: 2836 Biological Products, (No Diagnostic Substances)